NCT05577624View on ClinicalTrials.gov

A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Healthy Participants
Interventions
DRUG

AMG 510

Oral tablet

DRUG

Rifampin

Oral capsule

Trial Locations (1)

53704

Covance Clinical Research Unit, Inc 3402 Kinsman Boulevard, Madison

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY